dc.contributor.author
Franke, Barbara
dc.contributor.author
Michelini, Giorgia
dc.contributor.author
Asherson, Philip
dc.contributor.author
Banaschewski, Tobias
dc.contributor.author
Bilbow, Andrea
dc.contributor.author
Buitelaar, Jan K.
dc.contributor.author
Cormand Rifà, Bru
dc.contributor.author
Faraone, Stephen V.
dc.contributor.author
Ginsberg, Yiva
dc.contributor.author
Haavik, Jan
dc.contributor.author
Kuntsi, Jonna
dc.contributor.author
Larsson, Henrik
dc.contributor.author
Lesch, Klaus-Peter
dc.contributor.author
Ramos-Quiroga, Josep Antoni
dc.contributor.author
Réthelyi, János M.
dc.contributor.author
Ribasés Haro, Marta
dc.contributor.author
Reif, Andreas
dc.date.issued
2020-09-07T17:09:14Z
dc.date.issued
2020-09-07T17:09:14Z
dc.date.issued
2018-09-05
dc.date.issued
2020-09-07T17:09:15Z
dc.identifier
https://hdl.handle.net/2445/170368
dc.description.abstract
Attention-deficit/hyperactivity disorder (ADHD) is highly heritable and the most common neurodevelopmental disorder in childhood. In recent decades, it has been appreciated that in a substantial number of cases the disorder does not remit in puberty, but persists into adulthood. Both in childhood and adulthood, ADHD is characterised by substantial comorbidity including substance use, depression, anxiety, and accidents. However, course and symptoms of the disorder and the comorbidities may fluctuate and change over time, and even age of onset in childhood has recently been questioned. Available evidence to date is poor and largely inconsistent with regard to the predictors of persistence versus remittance. Likewise, the development of comorbid disorders cannot be foreseen early on, hampering preventive measures. These facts call for a lifespan perspective on ADHD from childhood to old age. In this selective review, we summarise current knowledge of the long-term course of ADHD, with an emphasis on clinical symptom and cognitive trajectories, treatment effects over the lifespan, and the development of comorbidities. Also, we summarise current knowledge and important unresolved issues on biological factors underlying different ADHD trajectories. We conclude that a severe lack of knowledge on lifespan aspects in ADHD still exists for nearly every aspect reviewed. We encourage large-scale research efforts to overcome those knowledge gaps through appropriately granular longitudinal studies.
dc.format
application/pdf
dc.publisher
Elsevier B.V.
dc.relation
Versió postprint del document publicat a: https://doi.org/10.1016/j.euroneuro.2018.08.001
dc.relation
European Neuropsychopharmacology, 2018, vol. 28, num. 10, p. 1059-1088
dc.relation
https://doi.org/10.1016/j.euroneuro.2018.08.001
dc.relation
info:eu-repo/grantAgreement/EC/H2020/667302/EU//CoCA
dc.relation
info:eu-repo/grantAgreement/EC/H2020/643051/EU//MiND
dc.rights
cc-by-nc-nd (c) Elsevier B.V., 2018
dc.rights
http://creativecommons.org/licenses/by-nc-nd/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject
Trastorns per dèficit d'atenció amb hiperactivitat en els infants
dc.subject
Trastorns per dèficit d'atenció amb hiperactivitat en els adults
dc.subject
Attention deficit disorder with hyperactivity in children
dc.subject
Attention deficit disorder with hyperactivity in adults
dc.title
Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/acceptedVersion